Status:
COMPLETED
Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead
Lead Sponsor:
Boston Scientific Corporation
Collaborating Sponsors:
Guidant Corporation
Conditions:
Ventricular Tachycardia
Ventricular Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the safety and efficacy of the implant of a ICD lead of defibrillation in the septum of the right ventricle
Detailed Description
The rate of success at implant and the positive clinical outcomes for the patients implanted with a lead of defibrillation at the septal site would make it possible to recommend this site as a "new st...
Eligibility Criteria
Inclusion
- ICD indication according to current Guidelines
Exclusion
- Indication for cardiac resynchronisation therapy, absence of spontaneous ventricular rhythm, pacemaker dependency
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT00180297
Start Date
April 1 2005
End Date
September 1 2012
Last Update
October 14 2021
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Amiens
Amiens, France, 80054
2
CHU Angers
Angers, France, 49033
3
CH Besancon
Besançon, France, 25030
4
CHU Clermont Ferrand
Clermont-Ferrand, France, 63003